Landgren, O., Trudel, S., Rosenblatt, J., McCurdy, A., Madan, S., Ali, S. A., Bahlis, N., Gabayan, E., Vescio, R., O'Gorman, M., Cheng, S., Jiang, S., Hoyle, M., Cheng, J., Vandendries, E., Raje, N. (2025). Safety and efficacy of elranatamab + nirogacestat in patients with relapsed or refractory multiple myeloma: Results from the Phase 1b MagnetisMM-4 study. Blood. https://doi.org/10.1182/blood-2025-4058